Provided by Tiger Trade Technology Pte. Ltd.

Cardiol Therapeutics Inc

2.15
+0.17508.86%
Post-market: 2.160.0062+0.29%16:48 EDT
Volume:2.10M
Turnover:4.38M
Market Cap:251.17M
PE:-9.11
High:2.19
Open:1.94
Low:1.93
Close:1.98
52wk High:2.28
52wk Low:0.8800
Shares:116.82M
Float Shares:92.07M
Volume Ratio:0.95
T/O Rate:2.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2360
EPS(LYR):-0.2835
ROE:-190.18%
ROA:-90.92%
PB:14.53
PE(LYR):-7.58

Loading ...

Company Profile

Company Name:
Cardiol Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
18
Office Location:
2265 Upper Middle Road East,Suite 602,Oakville,Ontario,Canada
Zip Code:
L6H 0G5
Fax:
- -
Introduction:
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.